XXXX @entity1002 in end-stage renal disease.

@entity1 @entity8 @entity101 @entity998 @entity5507 @entity1017 @entity741 @entity1011 @entity2742 @entity1002
To determine the factors associated with @entity998 @entity1002 ( @entity1002 ) in @entity8 ( @entity8 ), we performed echocardiography and gated cardiac scan on 217 nondiabetic dialysis and transplant @entity1 . The prevalence of @entity998 @entity1002 (ejection fraction less than 55% and left ventricular end diastolic diameter greater than or equal to 5.5 cm) in dialysis @entity1 was 18% and in transplant @entity1 2%. The 26 @entity1 with @entity1002 were compared to 52 controls without @entity1002 , matched by age, sex and year of starting treatment for @entity8 , but not for current @entity8 therapy. Mean age was 55 +/- (SEM) 14 years; 73% of the @entity1 in both groups were males. Duration of treatment for @entity8 was 5.6 +/- 4.3 years in @entity1 , compared to 5.1 +/- 4.1 years in controls. Significant differences between @entity1002 @entity1 and controls included current treatment (73% of cases were on hemodialysis and 8% were transplanted, compared to 48 and 42%; chi 2 = 9.9, p less than 0.01), high serum @entity1011 , smoking and high serum alkaline phosphatase. There were no differences for current blood pressure, proportion on treatment for @entity101 , left ventricular wall thickness, symptomatic @entity741 , proportion with functioning vascular access, degree of @entity1017 between dialyses, hemoglobin level or high transfusion requirement. Multiple logistic regression demonstrated the most significant and independent variables associated with @entity1002 were high alkaline phosphatase (suggestive of @entity2742 ), smoking and high serum @entity1011 levels (reflecting degree of @entity5507 ). Dialysis @entity1 with @entity1002 (n = 23) were compared to dialysis @entity1 who had normal echocardiograms (n = 29).(ABSTRACT TRUNCATED AT 250 WORDS)
